TORONTO, Sept. 20, 2017 (GLOBE NEWSWIRE) — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (TSXV:FIRE) is pleased to announce its wholly owned subsidiary, 7ACRES, has completed a sale of dried cannabis to Emerald Health Botanicals Inc. (“Emerald”), a wholly owned subsidiary of Emerald Health Therapeutics, Inc. (TSXV:EMH). Emerald is a Canadian Licensed Producer with a focus on advancing the science of medical cannabis through a deep commitment to research. All cannabis procured from 7ACRES by Emerald will be re-sold with a producer’s mark specifying the cannabis as “SunGrown by 7ACRES”.

“Emerald’s team has a depth of experience in life sciences and product development which is complementary to our focus on scaled cultivation. We see this transaction as the first step in building an ongoing relationship where each party can focus on its core competencies to develop competitive advantage,” stated John Fowler, CEO.

About Supreme

Supreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the ACMPR operating inside a 342,000 sq. ft. Hybrid Greenhouse facility. The Hybrid Greenhouse combines the best technology of indoor production with the efficiencies and sustainability of a greenhouse, in a single large-format production footprint. Please visit www.supreme.ca and www.7acres.com for more information.

John Fowler, President and CEO.

Contact Information

Investor Relations

202 – 20 De Boers Dr,

Toronto ON M3J 0H1

Phone: (416) 630-7272

Email: info@supreme.ca

Website: www.supreme.ca

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.